Dahlman Rose Raises Price Target on Baker Hughes to $95 (BHI)

Dahlman Rose is out with its report on Baker Hughes BHI, raising its PT to $95. In a note to clients, Dahlman Rose writes, "Improving fundamentals combined with a 'Top 3' market share in key growth products and low expectations built into estimates continue to support our bullish view. We are raising our price target to $95. Baker Hughes remains one of our top picks for 2011. We are raising our 2011 EPS to $4.11 from $3.52 and 2012 EPS to $5.15 from $4.71." BHI is trading at $63.84, up 2.44% from Tuesday's close.